Mirae Asset Global Investments Co. Ltd. Sells 18,560 Shares of The Clorox Company (NYSE:CLX)

Mirae Asset Global Investments Co. Ltd. reduced its holdings in The Clorox Company (NYSE:CLX - Free Report) by 44.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,931 shares of the company's stock after selling 18,560 shares during the period. Mirae Asset Global Investments Co. Ltd.'s holdings in Clorox were worth $3,270,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. GHP Investment Advisors Inc. lifted its stake in shares of Clorox by 1.3% in the fourth quarter. GHP Investment Advisors Inc. now owns 5,132 shares of the company's stock valued at $720,000 after buying an additional 66 shares during the period. Toroso Investments LLC grew its holdings in shares of Clorox by 1.3% during the 1st quarter. Toroso Investments LLC now owns 5,266 shares of the company's stock worth $833,000 after purchasing an additional 68 shares in the last quarter. First National Bank of Mount Dora Trust Investment Services increased its position in shares of Clorox by 3.2% during the fourth quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company's stock valued at $322,000 after purchasing an additional 71 shares during the period. Modera Wealth Management LLC lifted its position in Clorox by 1.4% in the third quarter. Modera Wealth Management LLC now owns 5,130 shares of the company's stock worth $672,000 after purchasing an additional 71 shares during the period. Finally, Czech National Bank boosted its stake in Clorox by 0.3% during the fourth quarter. Czech National Bank now owns 21,718 shares of the company's stock worth $3,097,000 after buying an additional 71 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 0.5 %

NYSE:CLX traded up $0.78 during trading hours on Thursday, hitting $143.12. 760,012 shares of the stock were exchanged, compared to its average volume of 1,203,849. The company has a market capitalization of $17.76 billion, a P/E ratio of 225.86, a price-to-earnings-growth ratio of 2.22 and a beta of 0.43. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The company's 50 day moving average is $150.40 and its two-hundred day moving average is $141.69. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $178.21.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm's revenue for the quarter was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.98 earnings per share. On average, sell-side analysts anticipate that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a dividend yield of 3.35%. The ex-dividend date is Tuesday, April 23rd. Clorox's payout ratio is 761.92%.

Wall Street Analyst Weigh In

CLX has been the subject of a number of recent research reports. Jefferies Financial Group upgraded shares of Clorox from an "underperform" rating to a "hold" rating and set a $145.00 price objective for the company in a research note on Tuesday, March 26th. Barclays dropped their price target on shares of Clorox from $148.00 to $136.00 and set an "underweight" rating for the company in a research report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft decreased their price objective on Clorox from $155.00 to $151.00 and set a "hold" rating on the stock in a report on Wednesday. Morgan Stanley reiterated an "equal weight" rating and issued a $160.00 price objective on shares of Clorox in a research note on Tuesday, March 26th. Finally, Citigroup cut their target price on Clorox from $165.00 to $155.00 and set a "neutral" rating for the company in a research report on Tuesday. Four research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $148.63.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.